Dermapharm Holding SE (FRA:DMP)

Market Cap	2.08B +15.4%
Revenue (ttm)	1.21B -1.4%
Net Income	146.54M +39.2%
EPS	2.77 +39.3%
Shares Out	n/a
PE Ratio	14.20
Forward PE	14.41
Dividend	0.88 (2.22%)
Ex-Dividend Date	Jun 29, 2026

Volume	n/a
Open	41.75
Previous Close	39.60
Day's Range	40.25 - 42.20
52-Week Range	31.85 - 50.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company a...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 3,503
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: DMP

Financial Performance

In 2025, Dermapharm Holding SE's revenue was 1.18 billion, a decrease of -1.43% compared to the previous year's 1.20 billion. Earnings were 132.41 million, an increase of 16.37%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error